Advertisement

Topics

MorphoSys received a milestone payment from Janssen

10:00 EDT 17 Apr 2019 | Bionity

MorphoSys AG announced that its licensee Janssen Research & Development, LLC, has further expanded the clinical development of guselkumab (Tremfya(R)) into familial adenomatous polyposis (FAP), a disease of the gastrointestinal tract. Janssen has initiated a phase 1b proof-of-concept clinical trial ...

Original Article: MorphoSys received a milestone payment from Janssen

NEXT ARTICLE

More From BioPortfolio on "MorphoSys received a milestone payment from Janssen"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...